LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global immunoprotein diagnostic testing market is expected to grow at a CAGR of close to 8% during the forecast period.
This research report titled ‘Global Immunoprotein Diagnostic Testing Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This report also includes an up to date analysis and forecasts for various market segments and all geographical regions.
According to Srinivas Sashidhar, a lead analyst at Technavio for in-vitro diagnostics research, “The global immunoprotein diagnostic testing market is expected to grow steadily during the forecast period. This will be due to the growth of the aging population and the growing prevalence of chronic diseases such as cancer, TB, malaria, diabetes, and cardiovascular diseases. Growing awareness about immunoprotein diagnostics testing, rapid advances in technology, and the increasing number of product approvals are also expected to drive the growth of the market during the forecast period.”
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
The market research analysis categorizes the global immunoprotein diagnostic testing market into four major application segments. They are:
- Infectious disease testing
- Oncology and endocrinology testing
- Autoimmune testing
- Allergy testing
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Infectious disease testing
The global infectious disease testing market is expected to grow steadily during the forecast period as the market has immense potential for growth. This is due to the increasing prevalence of viral diseases. Vendors are also developing new products for infectious disease testing. For instance, in April 2016, DiaSorin launched a new serological assay that can be used with the LIAISON Analyzer. The product launched was the LIAISON H. pylori IgG, which offers 90.4%- 98.4% positive results.
Oncology and endocrinology testing
The global oncology and endocrinology testing market is expected to grow rapidly during the forecast period. The high incidence of cancer and the growing need for diagnosis are expected to drive the growth of the market. Immunoprotein diagnostic tests that offer low-range sensitivity are now available in the market. For instance, VITROS Total PSA Assay II, which is offered by OrthoClinical Diagnostics, is a PSA test that provides analytical sensitivity outcomes by measuring a broad range of parameters to improve the monitoring of patients.
“Diabetes testing accounted for a major share among all endocrinology testing procedures. This was due to the increasing prevalence of type-1 and type-2 diabetes. The availability of advanced products improves diagnosis. Companies can partner with pharmaceutical companies to develop personalized or companion diagnostics,” says Srinivas.
The global autoimmune testing market will grow moderately during the forecast period. Autoimmune disease can involve in any cell or organ system. Autoimmune diseases range from rare and esoteric to relatively common and mainstream diseases such as celiac disease and rheumatoid arthritis (RA).
Companies are focusing on new tests that will increase the specificity and accuracy of results. In November 2016, Inova Diagnostics announced the FDA clearance of its QUANTA Lite Calprotectin Extended Range, which helps diagnose inflammatory bowel disease (IBD) by differentiating it from irritable bowel syndrome (IBS). It depicts the calprotectin levels accurately to help physicians determine critical cases and offer appropriate care to patients suffering from gastrointestinal disorders.
The global allergy testing market will grow moderately during the forecast period due to the increasing prevalence of allergies in APAC. There is a high incidence of asthma and allergies in Asia. There are several advanced products for allergy testing. Manufacturers are focusing on developing products with multi-panel testing. Such products can also diagnose allergies. Therefore, the need for separate allergy testing kits is expected to reduce, which will affect the growth of the global immunoprotein diagnostic testing market during the forecast period.
The top vendors highlighted by Technavio’s market research analysts in this report are:
- Beckman Coulter
- F. Hoffmann-La Roche
- Siemens Healthineers
Browse Related Reports:
- Global POC HbA1C Testing Market 2017-2021
- Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2017-2021
- Global Thyroid Functioning Tests Market 2017-2021
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.